Top 25 Companies in Global Bilirubin Meters Market (2025–2035): Statistics Report Till 2035 Forecast
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The global bilirubin meters market represents the worldwide market which produces, distributes, and sells devices that determine bilirubin levels in blood and through skin measurement. Bilirubin meters are the medical devices that measure bilirubin content in the blood of a patient and through the skin, which can be measured transcutaneous as well. These bilirubin meters are important to diagnose and monitor jaundice and other liver problems, especially in infants, and help to inform clinical decisions about patient care. The meters used for this purpose include both transcutaneous and serum types which doctors use to diagnose jaundice and monitor liver-related conditions in newborns and medical facilities. Bilirubin meters are rapidly evolving, incorporating advanced technologies for more accurate, non-invasive, and faster detection of bilirubin levels in patients. Consequently, expect continued progress toward faster, easier, and more accurate methods for diagnosing neonatal jaundice using bilirubin meters. These new technologies allow for non-invasive testing that provides faster results without the need for blood samples. August 2024: Governments are supporting the adoption of new point-of-care bilirubin testing devices, promoting accurate, rapid bilirubin level measurement in newborns to enhance early jaundice detection and prevent complications like kernicterus.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Meters Market.
Bilirubin Meters Market Size & Statistics
- The Market Size for Bilirubin Meters Was Estimated to be worth USD 194.75 Million in 2024.
- The Market is Going to Expand at a CAGR of 6.06% between 2025 and 2035.
- The Global Bilirubin Meters Market Size is anticipated to reach USD 372.11 Million by 2035.
- North America is expected to generate the highest revenue during the forecast period in the Bilirubin Meters Market
- Asia Pacific is expected to grow at the fastest rate during the forecast period in the Bilirubin Meters Market.
Market Segmentation
Global Bilirubin Meters Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Transcutaneous Bilirubin Meters, Serum Bilirubin Meters, Point-of-Care Bilirubin Testing Devices, and Others), By Measurement Technology (Spectrophotometric, Photometric, Electrochemical, and Others), By Application (Neonatal Jaundice Screening, Liver Function Monitoring, Hepatitis C, and Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Newborn Care Centers, Maternity Hospitals, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), and Global Bilirubin Meters Market Insights, Industry Trend, Forecasts 2024 to 2035
Regional growth and demand
Asia Pacific is expected to grow at the fastest rate during the forecast period in the Bilirubin Meters market. Asia Pacific is expected to grow at the fastest rate due to neonatal health care awareness, the rise in jaundice and liver-associated disorders, an increased number of hospital infrastructures, and an increased use of advanced non-invasive bilirubin monitoring devices, which will all contribute to the growth of this market. The important drivers are birth rates, awareness of neonatal health, development of hospital facilities, and increased use of non-invasive transcutaneous bilirubin meters, which will be the four leading factors in promoting growth in this area. Also, government programs in countries such as India are assisting with further advances in the industry.
North America is expected to generate the highest revenue during the forecast period in the Bilirubin Meters market. North America is expected to generate the highest revenue due to advanced health care infrastructure, the utmost use of modern diagnostic technology, and strongly regulated newborn screening programs. In addition, large-scale government and private sector funding exist for health care in this area as well. Including, with widespread use of transcutaneous bilirubin meters in hospitals and neonatal units in the USA, we can expect that an increase in early detection of jaundice will afford a large incentive for the growth of bilirubin meters.
Ready to lead the Bilirubin Meters Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in the Bilirubin Meters Market
- Non-invasive Transcutaneous Devices
- Point-of-Care Testing
- Integration with Digital Health Platforms
- AI & Automated Analysis
- Portable & Compact Devices
- Government Initiatives & Screening Programs
- Focus on High-Risk Infants
- Cloud-Based Data Management
- Cost-Effective & Eco-Friendly Devices
- Increasing Awareness of Neonatal Health
- Non-invasive Transcutaneous Devices
Transcutaneous bilirubin measurement devices measure bilirubin through the skin, meaning blood draws will no longer be necessary and testing will be done without pain; therefore, tests can be done much more quickly and safely, especially on newborns. The increasing number of hospitals and clinics using these types of devices is a major contributor to the reduction of the occurrences of kernicterus, resulting in the overall improvement of the level of care provided to babies during their neonatal period. Growth in awareness of non-invasive ways to monitor neonatal patients is driving global adoption, particularly in areas with high rates of birth.
- Point-of-Care Testing
Point-of-care bilirubin meters provide rapid, bedside testing, which enables clinicians to measure bilirubin levels through immediate testing instead of sending samples to laboratories. The trend provides three benefits because it improves diagnostic efficiency and decreases waiting times while enabling healthcare workers to provide immediate medical help to newborns. Hospitals and maternity units and clinics are increasing their use of these devices because they improve patient care and help staff members work more efficiently. The market is growing because people want fast and accurate testing results.
- Integration with Digital Health Platforms
Bilirubin meters are becoming more prevalent due to the integration of these devices with mobile applications, cloud computing, and EHR systems for tracking historical trends in bilirubin levels, remotely monitoring patients, and securely sharing data between providers. Using digital integration services supports clinical decision making, facilitates telemedicine applications, and provides for greater efficiency in the care of newborns. The rapid increase in emphasis on data-driven solutions in healthcare is aiding the global growth and use of connected bilirubin meters.
- AI & Automated Analysis
The development of bilirubin meters now uses artificial intelligence and automated algorithms to improve measurement precision and track future developments while decreasing operational mistakes. AI-powered devices support clinicians by providing real-time analysis and diagnostic confidence, especially in critical neonatal care. The combination of machine learning and predictive monitoring enables healthcare professionals to detect problems early, which leads to better patient results. The worldwide shift toward smart medical devices has increased because of rising investment in these technologies.
- Portable & Compact Devices
In hospitals, clinics and in-home care environments, lightweight, compact and portable bilirubin meters are becoming very popular. These devices can easily be transported from one place to another and will accommodate any user, they make a perfect tool for use in remote or rural health care facilities. Portable devices make it possible to monitor bilirubin levels during travel on the go, therefore increasing access to the early detection of jaundice for patients who live in underserved areas. Growing demand for neonatal care solutions that are more convenient, flexible and affordable will continue to drive the global acceptance of portable bilirubin meters.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the bilirubin meters market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Meters Market.
Top 25 Companies Leading the Bilirubin Meters Market
- Koninklijke Philips N.V.
- Drägerwerk AG & Co. KGaA
- Konica Minolta, Inc.
- Natus Medical Incorporated
- Apel Co., Ltd.
- Reichert Technologies (AMETEK)
- Mennen Medical Ltd.
- Advanced Instruments, LLC
- GINEVRI srl
- Lowenstein Medical GmbH
- AVI Healthcare Pvt. Ltd.
- Qili Medical
- Beijing M&B
- DAS Medical Systems
- Kejian Hi‑Tech Co., Ltd.
- Micro Lab Instruments
- Olidef Medical
- Dison Instrument & Meter Co., Ltd.
- Siemens Healthineers AG
- F. Hoffmann‑La Roche Ltd.
- Abbott Laboratories
- Shenzhen Mindray Bio‑Medical Electronics Co., Ltd.
- Delta Medical International Ltd.
- Aegis Medical Innovations Inc.
- Medi Waves Inc.
- Koninklijke Philips N.V.
Headquarters: Amsterdam, Netherlands
Philips operates as a top international health technology enterprise which specializes in diagnostic products and patient monitoring systems that include bilirubin meters designed for neonatal jaundice detection. The company uses its extensive research and development resources together with its international distribution network to deliver advanced clinical medical equipment to hospitals and clinics worldwide which enables early bilirubin monitoring and better neonatal treatment.
- Drägerwerk AG & Co. KGaA
Headquarters: Lübeck, Germany
The company Dräger has been providing engineering and medical technology products since its establishment at 1889 in Germany. The company offers products for patients in clinical settings, emergency situations, and babies requiring special care. Patient monitoring equipment such as patient ventilators, incubators for babies, and bilirubin measurement equipment is part of the company’s various product offerings worldwide. The company's commitment to innovation and excellence in providing accurate noninvasive testing for the measurement of bilirubin means that the company is well known for providing Neonatal Diagnostic Solutions on a global basis.
- Natus Medical Incorporated
Headquarters: Middleton, Wisconsin, USA
Natus Medical is a major American company that produces medical devices which focus on providing solutions for newborn care and neurodiagnostic needs and sensory system requirements. The company develops transcutaneous bilirubin meters, which include the BiliCare system to measure bilirubin levels without performing blood tests, thereby improving neonatal jaundice treatment. The company offers complete clinician support together with training materials, which lead to better results in newborn medical care.
- Apel Co., Ltd.
Headquarters: Kawaguchi, Japan
Since 1976, Apel, a historic Japanese corporation, has been creating, producing, and distributing optical analytical tools used for both diagnostics in hospitals, clinics, and laboratories as well as using these types of devices to measure bilirubin levels through the manufacture of bilirubin meters and other clinical tools that are utilized by Hospitals, Clinics, Laboratories, and to screen infants for Jaundice, etc. Apel distributes its bilirubin meters and diagnostic devices across over 60 countries, ensuring global access to reliable neonatal healthcare solutions.
- Konica Minolta, Inc.
Headquarters: Tokyo, Japan
Agilent Technologies, active in over 100 countries, providing instruments, software, reagents, and diagnostic solutions to laboratories worldwide. Agilent plays a significant role in the bilirubin meters market, particularly through its pathology and life-science divisions. The company develops antibodies and related reagents used in immunohistochemistry and molecular pathology testing. These antibodies are widely used by pathologists to identify disease-related proteins in tissue samples. The company’s diagnostic antibody products support cancer diagnostics, where specific antibodies are used to detect tumor biomarkers and classify cancer subtypes. These antibodies are integrated into Agilent’s pathology workflow solutions, which include automated staining instruments, detection systems, and digital pathology software. Agilent’s diagnostic antibody portfolio includes reagents used for detecting biomarkers associated with breast cancer, lung cancer, and other malignancies. These antibodies help clinicians determine disease characteristics and guide treatment decisions.
Are you ready to discover more about the bilirubin meters market?
The report provides an in-depth analysis of the leading companies operating in the global bilirubin meters market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Bilirubin Meters Market.
Company Profiles
- Koninklijke Philips N.V.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Drägerwerk AG & Co. KGaA
- Konica Minolta, Inc.
- Natus Medical Incorporated
- Apel Co., Ltd.
- Reichert Technologies (AMETEK)
- Mennen Medical Ltd.
- Advanced Instruments, LLC
- GINEVRI srl
- Others
Conclusion
The global bilirubin meters market is expected to expand substantially from 2024 to 2035, driven by rising neonatal healthcare demand worldwide. By 2035, the bilirubin meters global market is expected to rise to USD 372.11 million based on its current revenue of USD 194.75 million in 2024, therefore reflecting a compound annual growth rate (CAGR) of 6.06% over the next 10 years. The major factors contributing to this growth include: the increasing incidence of neonatal jaundice, increasing use of point-of-care (POC) testing, improving awareness about infant care, technological progress in developing and using noninvasive bilimetric technologies to measure bilirubin levels. The fastest-growing region is expected to be Asia Pacific because of increased awareness about neonatal care, increasing birth rates and government activity to promote and support additional neonatal healthcare resources. The country with the highest revenues will be North America, which has the best healthcare facilities and systems and processes in place to ensure high-quality care is provided to its newborns through the use of modern diagnostic devices. Notable companies leading this innovation include Koninklijke Philips, Drägerwerk Natus Medical, Apel Corporation, and Konica Minolta, using portable, Artificially Intelligent (AI), and digitally linked devices for bilirubin measurement to facilitate improved early detection, workflow efficiencies, and improved outcomes for neonates globally. Overall, the outlook remains positive with significant investment expected to continue in bringing new innovative, and more accurate and efficient means for monitoring and measuring bilirubin levels in neonates.
Our Report
https://www.sphericalinsights.com/reports/japan-fresh-fruits-market
https://www.sphericalinsights.com/reports/italy-contraceptive-devices-market
https://www.sphericalinsights.com/reports/italy-cybersecurity-market
https://www.sphericalinsights.com/reports/italy-beauty-and-personal-care-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?